HUMA
Ticker
Humacyte, Inc.
HUMA · Healthcare · Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered…Humacyte, Inc. (HUMA), in the Healthcare sector, has 2 disclosed filings on Paydirt over the trailing twelve months from 1 member of Congress: 1 purchase and 1 sale, 2 filed past the deadline. Filers took a median of 846 days from execution to disclosure, and the most recent trade was executed Aug 20 2025 and filed Aug 20 2025. The most active filer was Thomas H Tuberville with 2 filings.
Add to watchlistFilings, ttm
2
1 buy · 1 sell · 2 late
Traders, ttm
1
1 congress
Volume, ttmiDollar value disclosed in the window
$89K
estimated for Congress, as filed for insiders
Median delay
846d
execution to disclosure
Last traded
Aug 20 2025
Filed Aug 20 2025
ADViAverage daily dollar volume
$7.7M
market data
Share price · 12M
$0.61 (-65.4%)
Adjusted for splits and dividends.
Volume by month
Buys $49K
Sells $20.7M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
TTRecent filings
Thomas H TubervillePURCHASE
Senator (Joint)
$49K3 lots · $17K–80K bracket
Exec Mar 21 2024
Filed Aug 5 † Thomas H TubervilleSALE Senator (Joint) $41K
2 lots · $16K–65K bracket
Exec May 3 2024
Filed Aug 5 † Laura E NiklasonSALE President, CEO and Director $3.7M
2,241,045 sh across 3 lots
Exec Aug 18 2025
Filed Aug 20 2025 · 5:30 PM ET Brady W DouganSALE Director $3.7M
2,241,045 sh across 3 lots
Exec Aug 18 2025
Filed Aug 20 2025 · 5:30 PM ET Brady W DouganSALE Director $6.6M
1,500,000 sh across 3 lots
Exec Nov 18 2024
Filed Nov 20 2024 · 5:30 PM ET Laura E NiklasonSALE President, CEO and Director $6.6M
1,500,000 sh across 3 lots
Exec Nov 18 2024
Filed Nov 20 2024 · 5:30 PM ET Laura E NiklasonSALE President, CEO and Director $2.4M
446,378 sh across 2 lots
Exec Sep 9 2024
Filed Sep 11 2024 · 5:30 PM ET Brady W DouganSALE Director $2.4M
446,378 sh across 2 lots
Exec Sep 9 2024
Filed Sep 11 2024 · 5:30 PM ET